Drug Trial Radar · NCT01560624
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
Last checked: Nov 19, 2026Latest source record: Feb 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
690
Actual
Start
Jun 26, 2012
Primary completion
Jun 24, 2018
Study completion Jun 24, 2018
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Mar 22, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an international, multicenter, randomized, double-blind, placebo-controlled, event driven study in subjects with pulmonary arterial hypertension.
Conditions
- Pulmonary Arterial Hypertension
Interventions
Treprostinil DiolamineDrug
Active
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Clinical Worsening EventTime frame: From randomization to approximately 4 years
Locations
155 sites in 23 countries. Site status is shown where the registry gives one.
Arizona Pulmonary Specialists, Ltd.
Phoenix, Arizona
University of Arizona
Tucson, Arizona
University of California, San Francisco-Fresno
Fresno, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California-Davis Medical Group, Advanced Lung Disease/Transplant Program
Sacramento, California
David Geffen School of Medicine
Torrance, California
University of Colorado Hospital
Aurora, Colorado
University of Florida
Gainesville, Florida
University of Florida College of Medicine Jacksonville- Division of Pulmonary & Critical Medicine
Jacksonville, Florida
University of Florida College of Medicine Jacksonville
Jacksonville, Florida
University of Florida College of Medicine, Jacksonville
Jacksonville, Florida
Cleveland Clinic Florida
Weston, Florida
Emory University Hospital
Atlanta, Georgia
Augusta University
Augusta, Georgia
Piedmont - Georgia Lung Associates
Austell, Georgia
HeartCare Midwest
Peoria, Illinois
Indiana University Hospital
Carmel, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Kentuckiana Pulmonary Associates
Louisville, Kentucky
University of Maryland
Baltimore, Maryland
Tufts Medical Center
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
Beaumont Health
Troy, Michigan
Nebraska Medical Center
Omaha, Nebraska
Newark Beth Israel Medical Center
Newark, New Jersey
University of Rochester
Rochester, New York
Asheville Cardiology Associates
Asheville, North Carolina
University of Cincinnati
Cincinnati, Ohio
University Hospital
Cleveland, Ohio
The Ohio State University
Columbus, Ohio
Oregon Health and Science University
Portland, Oregon
Legacy Research Institute
Portland, Oregon
Perelman Center for Advanced Medicine; University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center - Presbyterian Cardiovascular Institute
Pittsburgh, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
The University of Texas Health Science Center at Houston
Houston, Texas
Sentara Cardiovascular Research Institute
Norfolk, Virginia
Virginia Commonwealth University
Richmond, Virginia
Aurora Saint Luke's Medical Center
Milwaukee, Wisconsin
Showing 40 of 155 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.